Zobrazeno 1 - 7
of 7
pro vyhledávání: '"PERMIT group"'
Autor:
Vibeke Fosse, Emanuela Oldoni, Florence Bietrix, Alfredo Budillon, Evangelos P. Daskalopoulos, Maddalena Fratelli, Björn Gerlach, Peter M. A. Groenen, Sabine M. Hölter, Julia M. L. Menon, Ali Mobasheri, Nikki Osborne, Merel Ritskes-Hoitinga, Bettina Ryll, Elmar Schmitt, Anton Ussi, Antonio L. Andreu, Emmet McCormack, on behalf of The PERMIT group
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background Personalised medicine is a medical model that aims to provide tailor-made prevention and treatment strategies for defined groups of individuals. The concept brings new challenges to the translational step, both in clinical relevan
Externí odkaz:
https://doaj.org/article/ce60f85cb71e465188b1050e2365f3b2
Autor:
Fosse, Vibeke, Oldoni, Emanuela, Gerardi, Chiara, Banzi, Rita, Fratelli, Maddalena, Bietrix, Florence, Ussi, Anton, Andreu, Antonio L, McCormack, Emmet, The Permit Group
Publikováno v:
Journal of Personalized Medicine
The introduction of personalized medicine, through the increasing multi-omics characterization of disease, brings new challenges to disease modeling. The scope of this review was a broad evaluation of the relevance, validity, and predictive value of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ba314c0882438083092828e8550813c
https://hdl.handle.net/11250/3025969
https://hdl.handle.net/11250/3025969
Autor:
Fosse, Vibeke, Oldoni, Emanuela, Bietrix, Florence, Budillon, Alfredo, Daskalopoulos, Evangelos P., Fratelli, Maddalena, Gerlach, Björn, Groenen, Peter M. A., Hölter, Sabine M., Menon, Julia M. L., Mobasheri, Ali, Osborne, Nikki, Ritskes-Hoitinga, Merel, Ryll, Bettina, Schmitt, Elmar, Ussi, Anton, Andreu, Antonio L., McCormack, Emmet, on behalf of The PERMIT group, Banzi, Rita
Publikováno v:
BMC Medicine; 1/8/2023, Vol. 21 Issue 1, p1-13, 13p
Autor:
Glaab, Enrico, Rauschenberger, Armin, Banzi, Rita, Gerardi, Chiara, Garcia, Paula, Demotes, Jacques, PERMIT group
Objective: To review biomarker discovery studies using omics data for patient stratification which led to clinically validated FDA-cleared tests or laboratory developed tests, in order to identify common characteristics and derive recommendations for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2658::393138a540cabbac499494042024d3e7
http://orbilu.uni.lu/handle/10993/50106
http://orbilu.uni.lu/handle/10993/50106
Autor:
Torres Moral, Teresa, Sanchez-Niubo, Albert, Monistrol-Mula, Anna, Gerardi, Chiara, Banzi, Rita, Garcia, Paula, Demotes-Mainard, Jacques, Haro, Josep Maria, The Permit Group, Imaz-Iglesia, Iñaki
Publikováno v:
Journal of Personalized Medicine
Personalized medicine requires large cohorts for patient stratification and validation of patient clustering. However, standards and harmonized practices on the methods and tools to be used for the design and management of cohorts in personalized med
Autor:
Superchi, Cecilia, Brion Bouvier, Florie, Gerardi, Chiara, Carmona, Montserrat, San Miguel, Lorena, Sanchez-Gomez, Luis Maria, Imaz-Iglesia, Iñaki, Garcia, Paula, Demotes, Jacques, Banzi, Rita, Porcher, Raphaël, PERMIT Group
Publikováno v:
BMJ Open
Repisalud
Instituto de Salud Carlos III (ISCIII)
Repisalud
Instituto de Salud Carlos III (ISCIII)
ObjectivePersonalised medicine (PM) allows treating patients based on their individual demographic, genomic or biological characteristics for tailoring the ‘right treatment for the right person at the right time’. Robust methodology is required f
Autor:
Fosse V; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Oldoni E; EATRIS ERIC, European Infrastructure for Translational Medicine, 1081 HZ Amsterdam, The Netherlands., Gerardi C; Centre for Health Regulatory Policies, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy., Banzi R; Centre for Health Regulatory Policies, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy., Fratelli M; Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy., Bietrix F; EATRIS ERIC, European Infrastructure for Translational Medicine, 1081 HZ Amsterdam, The Netherlands., Ussi A; EATRIS ERIC, European Infrastructure for Translational Medicine, 1081 HZ Amsterdam, The Netherlands., Andreu AL; EATRIS ERIC, European Infrastructure for Translational Medicine, 1081 HZ Amsterdam, The Netherlands., McCormack E; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Centre for Pharmacy, Department of Clinical Science, The University of Bergen, 5021 Bergen, Norway., The Permit Group
Publikováno v:
Journal of personalized medicine [J Pers Med] 2022 Jul 19; Vol. 12 (7). Date of Electronic Publication: 2022 Jul 19.